Patients who live in rural communities, Hispanic patients and Black patients with pre-existing diabetic retinopathy are less likely to receive annual diabetic eye exams than white patients, according to a recent Northwestern Medicine study.
Northwestern Medicine scientists have conducted the largest lifestyle-intervention trial for U.S. South Asians, helping build a larger body of research to better represent the diverse and vastly underrepresented group.
A recent publication has outlined the novel and practical approach to improving transplant equity pioneered by Northwestern’s African American Transplant Access Program.
A combination therapy improved progression-free survival in patients with metastatic castration-resistant prostate cancer with genetic mutations compared to either therapy alone or sequentially, according to results from a Northwestern Medicine-led clinical trial.
Scientists have found that pediatricians are more likely to have conversations with parents about gun safety and secure storage if they receive a “nudge” from an electronic health record.
Northwestern Medicine investigators have discovered that targeting the TIM3 protein in mouse models of low-grade astrocytoma increased survival compared to current immunotherapies, according to recent findings published in the Journal of Clinical Investigation.
A new therapeutic strategy developed by Northwestern investigators activated the gene expression necessary to regenerate cartilage growth within just four hours, according to findings from a recent study.
Proteomic analysis of blood samples from pregnant individuals did not improve risk prediction of hypertensive disorders of pregnancy compared to current methods, underscoring the demand for more accurate prediction tools, according to findings published in JAMA Cardiology.
Adolescents with severe obesity who received meal replacement therapy plus financial incentives experienced a greater reduction in body mass index compared to those who received meal replacement therapy alone, according to recent findings published in JAMA Pediatrics.
CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine.
